India registered 9.3 lakh cancer deaths, 2nd highest in Asia

India registered about 12 lakh new cancer cases and 9.3 lakh deaths in 2019, becoming the second highest contributor to the disease burden in Asia for that year, according to a new study published......

Merck to license oral Covid drug Molnupiravir to 5 Indian firms

Drug firm MSD has decided to enter into voluntary licensing agreements for investigational oral antiviral drug candidate 'Mmolnupiravir', which is being studied for the treatment of Covid-19, with......

India among top 10 countries with highest Type 1 diabetes prevalence: Lancet

An estimated 8.4 million people were living with Type 1 diabetes across the globe in 2021, and India was among the top ten countries with highest prevalence of the disease, according to a modelling......

'Follow zero tolerance': Health minister on cough syrup deaths

Asserting that India follows a zero-tolerance policy on spurious medicines, Union health minister Mansukh Mandaviya has said 71 companies have been issued show-cause notices following concerns......

India's external debt rises 8.2% to $620.7 bn till Mar 2022

India's external debt rose by 8.2 per cent year-on-year to $620.7 billion as of March 2022, which according to the finance ministry is sustainable. While 53.2 per cent of it was denominated in the......

Survey bats for enhanced govt spending in healthcare

An increase in government spending on the healthcare sector - from the current 1 per cent to 2.5-3 per cent of GDP - as envisaged in the National Health Policy 2017 could reduce out-of-pocket......

Serum Institute to start phase-2 trials of Oxford-AstraZeneca vaccine

The institute expects to complete both, phase-2 and 3 trials in India by the end of this year. Pune's Serum Institute of India (SII) is all set to start phase-2 clinical trials of the Oxford......